Revolution Medicines, Inc. (42Z)
XDUS
177.85
-0.65 (-0.36%)
Closed
Oct 8, 2026
Day's Range
177.85178.00
52 wk Range
39.40194.05
Financial Statements - 42Z - Revolution Medicines, Inc.
Revenue
0
Net Income
-1.13B▼ 88.5%
EBITDA
-1.07B▼ 57.6%
Free Cash Flow
-913.73M▼ 60.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 11.58M | 35.38M | 29.39M | 42.98M |
| Cost of Goods | - | - | - | - | - | - |
| Gross Profit | - | - | - | - | - | - |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -1.18B | -689.52M | -487.18M | -258.27M | -188M | -110.69M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | -15.39M | 1.79M | 115K | - | - | - |
| Pre Tax Income | -1.13B | -600.84M | -439.89M | -249.12M | -187.09M | -108.53M |
| Income Tax | 0 | -753K | -3.52M | -420K | 0 | -371K |
| Net Income | -1.13B | -600.09M | -436.36M | -248.70M | -187.09M | -108.15M |
| EPS Basic | -5.95 | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 |
| EPS Diluted | -5.95 | -3.58 | -3.86 | -3.08 | -2.57 | -2.01 |
| Basic Shares Outstanding | 190.12M | 167.73M | 118.59M | 83.90M | 75.77M | 57.10M |
| Diluted Shares Outstanding | 190.12M | 167.73M | 118.59M | 83.90M | 75.77M | 57.10M |
| Ebit | -1.10B | -689.52M | -439.58M | -249.12M | -187.07M | -108.45M |
| Ebitda | -1.07B | -682.02M | -430.27M | -239.46M | -179.74M | -101.91M |
| Net Income Continuous Operations | -1.13B | -600.09M | -436.36M | -248.70M | -187.09M | -108.15M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | - | 0 | - | - | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
